KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Other financing activities (2019 - 2025)

Vir Biotechnology's Other financing activities history spans 5 years, with the latest figure at -$2000.0 for Q4 2025.

  • On a quarterly basis, Other financing activities fell 115.38% to -$2000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$28000.0, a 83.03% increase, with the full-year FY2025 number at -$361000.0, down 118.79% from a year prior.
  • Other financing activities hit -$2000.0 in Q4 2025 for Vir Biotechnology, down from $1000.0 in the prior quarter.
  • Over the last five years, Other financing activities for VIR hit a ceiling of $100000.0 in Q1 2023 and a floor of -$387000.0 in Q4 2023.
  • Historically, Other financing activities has averaged -$89125.0 across 4 years, with a median of -$21000.0 in 2024.
  • Biggest five-year swings in Other financing activities: skyrocketed 103.36% in 2024 and later plummeted 115.38% in 2025.
  • Tracing VIR's Other financing activities over 4 years: stood at -$260000.0 in 2022, then tumbled by 48.85% to -$387000.0 in 2023, then skyrocketed by 103.36% to $13000.0 in 2024, then plummeted by 115.38% to -$2000.0 in 2025.
  • Business Quant data shows Other financing activities for VIR at -$2000.0 in Q4 2025, $1000.0 in Q3 2025, and $13000.0 in Q4 2024.